Read Our Research
Open Label Study published in Brain Stimulation Journal.
Conditions We Treat
Transcranial Magnetic Stimulation (TMS) is a novel form of Brain Stimulation used to treat patients whose condition(s) has not improved through conventional approaches.
Read about our patients' success stories. In a series of documented case studies by Dr. Stubbeman, see the effect of TMS as a treatment solution for conditions such as depression and anxiety.
What Sets Us Apart
Our Unique Treatment Approach
What Patients Are Saying
What Our Patients Say About Us
Depression Treatment Results
Most Recent 7 Consecutive Patients
Latest News and Research
Theta-Burst Transcranial Magnetic Stimulation for Post Traumatic Stress DisorderTranscranial magnetic stimulation (TMS) offers a novel approach to those suffering with Posttraumatic stress disorder (PTSD).
Research Explores Neurocognitive Profile, Cognitive Impairment in MDDA literature review provided new insight into the clinical neurocognitive profile in major depressive disorder (MDD) and its relationship to cognitive deficits.
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorderToday, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulationPotentiating current antidepressant treatment is much needed. Based on animal studies, caffeine may augment the effects of currently available antidepressants.
TMS Condensed! Rapid Acting With Improved Remission Rates With SAINTRichard A. Bermudes, M.D. Read Full Story Here Potentiating current antidepressant treatment is much needed. Based on animal studies, caffeine…
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major DepressionNolan R. Williams, M.D. Read Full Story Here On September 6, 2022, the U.S. Food and Drug Administration cleared the…
Personalizing rTMS Parameters For Depression Treatment Using Multimodal NeuroimagingRepetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment to neuropsychiatric disorders such as major depressive disorder (MDD).
Neuromodulation Therapy May Improve Treatment-Resistant DepressionA high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.